Covered recipient · General Payments record
LAUREN KELLY SHEA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2020–2024
$4,097.24
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,400.00 | 1 |
| Travel and Lodging | $1,130.25 | 3 |
| Food and Beverage | $383.04 | 5 |
| Education | $60.50 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acrotech Biopharma Inc. | $3,799.71 | 6 |
| Kyowa Kirin, Inc. | $79.51 | 1 |
| Ipsen Biopharmaceuticals, Inc | $60.50 | 1 |
| Kite Pharma, Inc. | $34.07 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Acrotech Biopharma Inc. | $120.22 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147106152 | CMS |
| Acrotech Biopharma Inc. | $150.93 | 10/24/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147106154 | CMS |
| Acrotech Biopharma Inc. | $149.24 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147106156 | CMS |
| Acrotech Biopharma Inc. | $918.95 | 10/25/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147106158 | CMS |
| Acrotech Biopharma Inc. | $60.37 | 10/25/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147106160 | CMS |
| Acrotech Biopharma Inc. | $2,400.00 | 12/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147106162 | CMS |
| Ipsen Biopharmaceuticals, Inc | $60.50 | 10/25/2024 | Education | Undisputed | 01/23/2026 | 1091988815 | CMS |
| Kite Pharma, Inc. | $18.27 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128612891 | CMS |
| Kite Pharma, Inc. | $15.80 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128612889 | CMS |
| Kyowa Kirin, Inc. | $79.51 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127035404 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2020 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.